Sponsor or institution
Clinical trials and research at GERCOR - Multidisciplinary Oncology Cooperative Group
As of November 12, 2026, Find a Trial lists 9 clinical trials run by GERCOR - Multidisciplinary Oncology Cooperative Group that are recruiting, at sites in 2 countries (most in France (9), Italy (1)). By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 2Countries
Newest trials
All recruiting trials (9)
-
Trimodal prehabilitation program for patients with upper GI and pancreatic cancer
This study is testing an 8-week program that combines exercise, nutrition help, and mental support for patients with pancreatic or esophageal cancer to see if it can improve their health before surgery.
-
Combining EXL01 with Nivolumab and FOLFOX for treating advanced gastric cancer
This study is testing a new combination of treatments for advanced gastric cancer to see if it works better than the standard treatment for patients with a specific level of a protein called PD-L1.
-
Using dostarlimab to avoid surgery in localized gastric cancer
This study is testing if the drug dostarlimab can help patients with certain types of stomach cancer avoid surgery by seeing if their cancer completely responds to treatment.
-
Acupuncture for treating nerve pain caused by chemotherapy in cancer patients
This study is testing if acupuncture can help cancer patients with nerve pain caused by chemotherapy feel better after stopping their treatment.
-
Exploring blood biomarkers in colorectal cancer patients after liver surgery
This study is testing if blood samples can help predict how well colorectal cancer patients do after surgery to remove liver tumors.
-
Identifying markers to predict treatment response in pancreatic cancer patients
This study is trying to find markers that can help doctors predict how well different treatments will work for people with pancreatic cancer.
-
Combining nivolumab and ipilimumab for advanced colorectal cancer resistant to anti-PD1 treatment
This study is testing if combining two cancer drugs, nivolumab and ipilimumab, can help people with advanced colorectal cancer that hasn't responded to other treatments.
-
Identifying markers to predict treatment response in bile duct cancer
This study is trying to find markers that can help doctors predict how well different treatments will work for people with bile duct cancer.
-
Neoadjuvant chemotherapy for localized digestive neuroendocrine carcinomas
This study is testing a new 12-month chemotherapy treatment for people with localized digestive neuroendocrine carcinomas to see if it helps them live longer without the cancer coming back after surgery.
Quick answers
How many clinical trials run by GERCOR - Multidisciplinary Oncology Cooperative Group are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in France (9 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.